TY - JOUR
T1 - Impact of [ 11C]methionine positron emission tomography for target definition of glioblastoma multiforme in radiation therapy planning
AU - Matsuo, Masayuki
AU - Miwa, Kazuhiro
AU - Tanaka, Osamu
AU - Shinoda, Jun
AU - Nishibori, Hironori
AU - Tsuge, Yusuke
AU - Yano, Hirohito
AU - Iwama, Toru
AU - Hayashi, Shinya
AU - Hoshi, Hiroaki
AU - Yamada, Jitsuhiro
AU - Kanematsu, Masayuki
AU - Aoyama, Hidefumi
PY - 2012/1/1
Y1 - 2012/1/1
N2 - Purpose: The purpose of this work was to define the optimal margins for gadolinium-enhanced T 1-weighted magnetic resonance imaging (Gd-MRI) and T 2-weighted MRI (T 2-MRI) for delineating target volumes in planning radiation therapy for postoperative patients with newly diagnosed glioblastoma multiforme (GBM) by comparison to carbon-11-labeled methionine positron emission tomography ([ 11C]MET-PET) findings. Methods and Materials: Computed tomography (CT), MRI, and [ 11C]MET- PET were separately performed for radiation therapy planning for 32 patients newly diagnosed with GBM within 2 weeks after undergoing surgery. The extent of Gd-MRI (Gd-enhanced clinical target volume [CTV-Gd]) uptake and that of T 2-MRI of the CTV (CTV-T 2) were compared with the extent of [ 11C]MET-PET (CTV - [ 11C]MET-PET) uptake by using CT - MRI or CT - [ 11C]MET-PET fusion imaging. We defined CTV-Gd (x mm) and CTV-T 2 (x mm) as the x-mm margins (where x = 0, 2, 5, 10, and 20 mm) outside the CTV-Gd and the CTV-T 2, respectively. We evaluated the relationship between CTV-Gd (x mm) and CTV - [ 11C]MET-PET and the relationship between CTV-T 2 (x mm) and CTV - [ 11C]MET-PET. Results: The sensitivity of CTV-Gd (20 mm) (86.4%) was significantly higher than that of the other CTV-Gd. The sensitivity of CTV-T 2 (20 mm) (96.4%) was significantly higher than that of the other CTV-T 2 (x = 0, 2, 5, 10 mm). The highest sensitivity and lowest specificity was found with CTV-T 2 (x = 20 mm). Conclusions: It is necessary to use a margin of at least 2 cm for CTV-T 2 for the initial target planning of radiation therapy. However, there is a limit to this setting in defining the optimal margin for Gd-MRI and T 2-MRI for the precise delineation of target volumes in radiation therapy planning for postoperative patients with GBM.
AB - Purpose: The purpose of this work was to define the optimal margins for gadolinium-enhanced T 1-weighted magnetic resonance imaging (Gd-MRI) and T 2-weighted MRI (T 2-MRI) for delineating target volumes in planning radiation therapy for postoperative patients with newly diagnosed glioblastoma multiforme (GBM) by comparison to carbon-11-labeled methionine positron emission tomography ([ 11C]MET-PET) findings. Methods and Materials: Computed tomography (CT), MRI, and [ 11C]MET- PET were separately performed for radiation therapy planning for 32 patients newly diagnosed with GBM within 2 weeks after undergoing surgery. The extent of Gd-MRI (Gd-enhanced clinical target volume [CTV-Gd]) uptake and that of T 2-MRI of the CTV (CTV-T 2) were compared with the extent of [ 11C]MET-PET (CTV - [ 11C]MET-PET) uptake by using CT - MRI or CT - [ 11C]MET-PET fusion imaging. We defined CTV-Gd (x mm) and CTV-T 2 (x mm) as the x-mm margins (where x = 0, 2, 5, 10, and 20 mm) outside the CTV-Gd and the CTV-T 2, respectively. We evaluated the relationship between CTV-Gd (x mm) and CTV - [ 11C]MET-PET and the relationship between CTV-T 2 (x mm) and CTV - [ 11C]MET-PET. Results: The sensitivity of CTV-Gd (20 mm) (86.4%) was significantly higher than that of the other CTV-Gd. The sensitivity of CTV-T 2 (20 mm) (96.4%) was significantly higher than that of the other CTV-T 2 (x = 0, 2, 5, 10 mm). The highest sensitivity and lowest specificity was found with CTV-T 2 (x = 20 mm). Conclusions: It is necessary to use a margin of at least 2 cm for CTV-T 2 for the initial target planning of radiation therapy. However, there is a limit to this setting in defining the optimal margin for Gd-MRI and T 2-MRI for the precise delineation of target volumes in radiation therapy planning for postoperative patients with GBM.
UR - http://www.scopus.com/inward/record.url?scp=83955162981&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=83955162981&partnerID=8YFLogxK
U2 - 10.1016/j.ijrobp.2010.09.020
DO - 10.1016/j.ijrobp.2010.09.020
M3 - Article
C2 - 21095072
AN - SCOPUS:83955162981
SN - 0360-3016
VL - 82
SP - 83
EP - 89
JO - International Journal of Radiation Oncology Biology Physics
JF - International Journal of Radiation Oncology Biology Physics
IS - 1
ER -
